[go: up one dir, main page]

WO2008105473A1 - 抗悪性腫瘍薬 - Google Patents

抗悪性腫瘍薬 Download PDF

Info

Publication number
WO2008105473A1
WO2008105473A1 PCT/JP2008/053442 JP2008053442W WO2008105473A1 WO 2008105473 A1 WO2008105473 A1 WO 2008105473A1 JP 2008053442 W JP2008053442 W JP 2008053442W WO 2008105473 A1 WO2008105473 A1 WO 2008105473A1
Authority
WO
WIPO (PCT)
Prior art keywords
tumor agent
tumor
malignant
agent
ability
Prior art date
Application number
PCT/JP2008/053442
Other languages
English (en)
French (fr)
Inventor
Yasushi Arano
Hiromichi Akizawa
Masahiro Kurokawa
Satoshi Matsushima
Kiyonori Hatsushiba
Original Assignee
National University Corporation Chiba University
Fujifilm Ri Pharma Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National University Corporation Chiba University, Fujifilm Ri Pharma Co., Ltd. filed Critical National University Corporation Chiba University
Priority to JP2009501284A priority Critical patent/JP5156733B2/ja
Publication of WO2008105473A1 publication Critical patent/WO2008105473A1/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
    • A61K51/0406—Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

【課題】より優れた腫瘍集積効果、腫瘍縮小効果の高い抗腫瘍薬を提供すること。 【解決手段】　下記式（１）に記載の化合物を有効成分として含有する抗腫瘍薬。 【化１】 （上記式中Ｒ１、Ｒ２、Ｒ３は水素原子、アルキル基又はベンジル基であり、Ｒ１、Ｒ２、Ｒ３は同じであっても、互いに異なっていても良い。またＸ＊は放射性ハロゲン原子を示す。）
PCT/JP2008/053442 2007-02-28 2008-02-27 抗悪性腫瘍薬 WO2008105473A1 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009501284A JP5156733B2 (ja) 2007-02-28 2008-02-27 抗悪性腫瘍薬

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007050776 2007-02-28
JP2007-050776 2007-02-28

Publications (1)

Publication Number Publication Date
WO2008105473A1 true WO2008105473A1 (ja) 2008-09-04

Family

ID=39721297

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/053442 WO2008105473A1 (ja) 2007-02-28 2008-02-27 抗悪性腫瘍薬

Country Status (2)

Country Link
JP (1) JP5156733B2 (ja)
WO (1) WO2008105473A1 (ja)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6426586A (en) * 1987-06-24 1989-01-27 Dow Chemical Co Functionalized polyamine chelating agent and its rhodium complex and production thereof
JPH04504247A (ja) * 1988-06-24 1992-07-30 ザ　ダウ　ケミカル　カンパニー 大環状二官能キレート剤、その錯体及びそれらの抗体接合体

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6426586A (en) * 1987-06-24 1989-01-27 Dow Chemical Co Functionalized polyamine chelating agent and its rhodium complex and production thereof
JPH04504247A (ja) * 1988-06-24 1992-07-30 ザ　ダウ　ケミカル　カンパニー 大環状二官能キレート剤、その錯体及びそれらの抗体接合体

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BONGARD J.E. ET AL.: "Monofunctionalized tetraazacrowns for use in bioconjugation and catalysis", SYNTHESIS AND REACTIVITY IN INORGANIC, METAL-ORGANIC, AND NANO-METAL CHEMISTRY, vol. 35, no. 9, 2005, pages 727 - 731 *

Also Published As

Publication number Publication date
JP5156733B2 (ja) 2013-03-06
JPWO2008105473A1 (ja) 2010-06-03

Similar Documents

Publication Publication Date Title
MX2010003394A (es) Derivado de gamma-aminoacido biciclico.
TW200612958A (en) Substituted imidazole derivatives
WO2009135179A3 (en) The use of solid carrier particles to improve the processability of a pharmaceutical agent
UA99908C2 (ru) Пиридопиразиновые производные, способ борьбы с растениями, гербицидные композиции
WO2006116733A3 (en) Protein kinase inhibitors
MY154772A (en) Harmful arthropod control composition, and fused heterocyclic compound
TW200642689A (en) Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
MY148703A (en) Polycyclic cinnamide derivatives
MX2011008176A (es) Derivados de 3,3'-espiroindolinona como agentes anticancerigenos.
NZ577916A (en) Cyclopamine analogs
WO2010026436A3 (en) 1,3, 4, 6, 7, 11b-hexahydro-benzo[alpha]quinolizines for the treatment of hyperkinetic movement and related disorders
MX2009007713A (es) Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas.
WO2012030685A3 (en) Indazole derivatives useful as erk inhibitors
WO2008108323A1 (ja) インフルエンザ治療剤
MX2013003019A (es) Compuestos de azabenzotiazol, composiciones y metodos de uso.
WO2008057775A3 (en) Heterocyclic amide compounds useful as kinase inhibitors
MY147188A (en) Substituted imidazole compounds as ksp inhibitors
WO2009047298A3 (en) Dimers of harmol or of its derivatives and uses thereof
WO2006125555A3 (de) Chinazolinone
UA96759C2 (en) 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS
MX2009005071A (es) Compuestos de pirazol y triazol sustituidos como inhibidores de ksp.
WO2008003854A3 (fr) Derives de 2-benzoyl-imidazopyridines, leur preparation et leur application en therapeutique
TW200738697A (en) Benzimidazole derivatives as 5-HT6,5-HT24
SI1845780T1 (sl) Uporaba derivatov metilfenidata
WO2009063897A1 (ja) 皮膚の乾癬予防または改善剤

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08712064

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2009501284

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08712064

Country of ref document: EP

Kind code of ref document: A1